WINDTREE THERAPEUTICS INC /DE/

Profile

Company Names

WINDTREE THERAPEUTICS INC /DE/
DISCOVERY LABORATORIES INC /DE/

Addresses

2600 KELLY ROAD, SUITE 100, WARRINGTON, PA 18976

Phone Numbers

2154889300

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$52,415,603.00

Number of Funding Rounds:

12
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
12
2019-12-06 
$26,424,996.00 
$26,424,996.00 
$0.00 
Equity 
11
2018-12-21 
$1,000,000.00 
$1,000,000.00 
$0.00 
Equity 
10
2018-07-02 
$1,500,000.00 
$1,500,000.00 
$0.00 
 
9
2018-03-30 
$2,600,000.00 
$2,600,000.00 
$0.00 
Equity 
8
2017-10-27 
$10,307,632.00 
$10,307,632.00 
$0.00 
Equity 
7
2017-02-13 
$10,538,000.00 
$10,538,000.00 
$0.00 
Equity 
6
2014-10-10 
$0.00 
$7,500,000.00 
$7,500,000.00 
 
5
2013-12-03 
$0.00 
$13,094,600.00 
$13,094,600.00 
 
4
2013-08-31 
$14,525.00 
$58,100.00 
$43,575.00 
Equity 
3
2013-05-24 
$12,000.00 
$12,000.00 
$0.00 
Equity 
2
2013-02-28 
$18,450.00 
$18,450.00 
$0.00 
Equity 
1
2013-02-13 
$0.00 
$6,575,400.00 
$6,575,400.00 
 
People
First Name
Middle Name
Last Name
Titles
Related Companies
RUSSELL 
 
CLAYTON, D.O. 
EXECUTIVE OFFICER
KATHRYN 
 
COLE 
EXECUTIVE OFFICER
JOHN 
C. 
COOPER 
EXECUTIVE OFFICER, DIRECTOR
JOHN 
G. 
COOPER 
EXECUTIVE OFFICER, DIRECTOR
GEORGE 
 
COX 
EXECUTIVE OFFICER
CRAIG 
 
FRASER 
EXECUTIVE OFFICER, DIRECTOR
CRAIG 
E. 
FRASER 
EXECUTIVE OFFICER, DIRECTOR
THOMAS 
C. 
HOY 
EXECUTIVE OFFICER
MICHAEL 
L. 
MAGEE 
EXECUTIVE OFFICER
JOSEPH 
 
MAHADY 
DIRECTOR
JOSEPH 
M. 
MAHADY 
DIRECTOR
THOMAS 
F. 
MILLER, PH.D., MBA 
EXECUTIVE OFFICER
MARVIN 
E. 
ROSENTHALE 
DIRECTOR
MARVIN 
E. 
ROSENTHALE, PH.D. 
DIRECTOR
BRIAN 
 
SCHREIBER 
DIRECTOR
STEVEN 
 
SIMONSON 
EXECUTIVE OFFICER
STEVEN 
A. 
SIMONSON 
EXECUTIVE OFFICER
JOHN 
 
TATTORY 
EXECUTIVE OFFICER
JOHN 
A. 
TATTORY 
EXECUTIVE OFFICER
MARY 
B. 
TEMPLETON 
EXECUTIVE OFFICER
MARY 
B. 
TEMPLETON, ESQ. 
EXECUTIVE OFFICER
LAWRENCE 
A. 
WEINSTEIN 
EXECUTIVE OFFICER
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2019-12-06 
D
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2018-12-21 
D/A
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
$1,000,001 - $5,000,000 
Equity 
2018-03-30 
D
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
$1,000,001 - $5,000,000 
 
2018-07-02 
D
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
$1,000,001 - $5,000,000 
Equity 
2018-03-30 
D
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
$1,000,001 - $5,000,000 
Equity 
2017-10-27 
D
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
$1,000,001 - $5,000,000 
Equity 
2017-02-13 
D
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
$1 - $1,000,000 
 
2014-10-10 
D
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
$1 - $1,000,000 
 
2013-12-03 
D
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
NO REVENUES 
Equity 
2013-08-31 
D
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
NO REVENUES 
Equity 
2013-05-24 
D
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
NO REVENUES 
Equity 
2013-02-28 
D
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
NO REVENUES 
 
2013-02-13 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
RUI JIN (HK) CONSULTING MANAGEMENT COMPANY LIMITED
NONE